SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Randy Schmid who wrote (1909)9/29/1997 9:39:00 PM
From: JOHN W.   of 6136
 
I wrote the editor. He e-mailed me thanking me for my letter and said they will post it. Essentially, they were just reporting news in a unbiased manner. If data is presented that demonstartes a favorable cross resistance profile, then they would report that in a similiar way. If favorable-contradictory to todays ridiculous study data is presented and the street.com does not devote a large portion of the day with major "exclusive" headlines favorable to Agouron, then that would be rather suspicious. Lets see what happens, for if such data is released and the street.com ignores the same type of positive ICAAC study results, we will know there was something more that just reporting news and an SEC investigation would then be warranted (IMHO) on this rather suspicious major headline coverage in Barrons and the street.com on this little Biotech with a 1.3B mkt cap.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News